SignifyMD makes expert medical insights accessible and actionable for today’s oncologists and HCPs.
#Oncology #Cancer #MedTwittersignifymd.comJoined June 2024
⭐️#HemOnc Fellowship Tips
👉Continuity Clinic New Patient WorkFlow:
1️⃣ Chart Review Prior to Clinic Day
2️⃣ Watch the @OncBrothers treatment alogorithm with expert special guests.
3️⃣Review @NCCN + institute guidelines and finalize plan
#OncTwitter@HemOncFellows@ASCOTECAG
Here is the full speaker and panel list for our forum! also a QR code to register - there is still time! This forum is designed for patients, interested folks and all others! including oncologists. @OncoAlert@OncBrothers
Join us tomorrow for the next City of Hope Breast Cancer Forum! @hoperugo and @cityofhope experts will discuss how integrative oncology approaches can support breast cancer care, survivorship, and overall well-being during and after treatment.
Register: bit.ly/4dVPogm
My first #lead2026 was one for the books!
- cancer updates
- AI + medicine
- mentorship
-advocacy
- negotiation
- watched @rachnatshroff beautiful acceptance speech -woman oncologist of the yr
We laughed + cried and came out stronger than ever! Cheers to this wolf pack!
I can’t think of anyone who has met @rachnatshroff and hasn’t been moved by her dynamic, vibrant spirit. Thousands are deeply inspired by her dedication to cancer research, #volunteerism, and #mentorship.
Now, she is turning an incredibly difficult journey into a lasting legacy by raising funds to support future generations ❤️
We’re almost there. Let’s join hands and help make this extraordinary vision a reality. ❤️
support.conquer.org/p2p/site/17Smz…
10 new @FDA indications in #bcsm in 20 weeks - May to September, 2026.
Three firsts in there: first PROTAC in any cancer, first CDK4/6 inhibitor in HER2+ #bcsm, first drug approval triggered by ctDNA prior radiographic progression.
#clinicaltrials win! Patients win!
Three things I recommend for using Bispecific antibodies in myeloma:
1) Prophylactic tocilizumab with first dose
2) Monthly IVIG regardless of the IgG level
3) Consider reducing frequency/stopping after excellent response.
This applies to all the approved bispecifics: teclistamab, elranatamab, linvoseltamab, and talquetamab.
Academic centers with expertise and close monitoring capabilities may skip the prophylactic tocilizumab but in general I do not see community adoption without it.
The data on routine IVIG and early use before the IgG levels drop or infections occur is good and sufficient to move forward. It’s recommended in NCCN and mSMART. Bispecifics are better at controlling myeloma than standard triplets and quads, but pose a much higher risk of serious life threatening infections without prophylaxis and careful adjustment of dosing schedule based on response and patient characteristics.
#IMS26
Congrats @TimothyJBrownMD!! We’re proud of the incredible oncologist, researcher and most importantly the great human being and friend that you are. Good luck on the new chapter. @NateraOncology is lucky to have you! @TheGutOncLab@GIMedOnc
Pleased to announce as of next week that I will be joining @NateraOncology as a medical director in GI oncology.
I’m grateful for the 8 years at UTSW and the opportunity to grow as a GI oncologist. Looking forward to advancing the science of MRD and precision onc in GI cancers
Rusfertide (subcutaneous, hepcidin mimetic) now @US_FDA ✅ based off #VEIRFY study, Ph III (vs Placebo) in phlebotomy dependent polycythemia vera.
- Improved need of phlebotomy.
- Hct control: 76.9% vs 32.9%
- Improved symptoms/fatigue
#MPNsm#HemeTwitter#OncTwitter
2 Followers 2K FollowingCansado de litigios lentos y caros?
TOGA: Todos Ganan
Mediación: laboral, comercial, empresarial y tributaria.
Soluciones rápidas, y mutuamente beneficiosas.
541 Followers 522 FollowingMedical Gynecologic Oncologist and Researcher, UCLA | Hematology/Oncology Chief Fellow, UCLA | UCSF Internal Medicine | Duke University BS | Opinions my own
1K Followers 230 FollowingDirector of Multiple Myeloma Program and Professor of Clinical Medicine, University of California San Francisco. Views are my own.
1K Followers 6K FollowingBreast Cancer Biologist | Associate Director of Education and Training | Mentoring bright minds to conquer cancer | Posts = my views
291 Followers 355 FollowingDad and husband | @DukeGUCancer GU Oncologist, DCI Center for Prostate and Urologic Cancers | Former @UNC Hem/Onc Chief Fellow | @vtcsom grad | Phase 1 trials
3K Followers 908 FollowingAssociate clinical professor at UCI focused on CLL/SLL with side interest in CHIP/CCUS. APD for hem/onc fellowship. Animal/nature lover. Tweets are my own.
560 Followers 2K FollowingHealthcare education professional @PeerView dedicated to improving patient care via #MedEd. Tweets are my own. More info at https://t.co/UOjjiYNSM4
17K Followers 839 FollowingProfessor of Oncology. Med Onc. PI @oncologyBGLab #groundshot. Pubs: https://t.co/FTRPKNySfB Talks- https://t.co/anav3AJx9m
Personal Account.
366 Followers 78 FollowingThoracic medical oncologist @ColumbiaMed. Lucky mother of two lovely children. Board game, food, and grammar enthusiast. Views my own.
394 Followers 137 FollowingGeriatric Oncologist specializing in breast cancer, SOCARE Clinic Director @WilmotCancer. Research focus in cognition in older adults with cancer #BeesonScholar
6K Followers 2K FollowingDirector, Center for Cancer & Aging
Vice Chair for Academic Affairs
Department of Supportive Care Medicine
City of Hope
#GeriOnc #SupportiveCare #Hiking
6K Followers 4K FollowingAssociate Director @SylvesterCancer. Director #Sarcoma and #GIST. Telemedicine and in-person clinics are open. Tweets are my own.
6K Followers 950 FollowingNeurologist and Nerve Pathology Lab Director @MayoClinic. Vice-Chair of Education @PNSociety1. Check my highlights to learn more about peripheral neuropathy.
24K Followers 3K FollowingProfessor of Hematology; past-president of the EBMT; Chairman of the IACH; Editor in Chief: Bone Marrow Transplant; Clin Hematol Int.
3K Followers 389 Following@HopkinsMedicine faculty. MPN, MDS/MPN, BMT, CAR T catch my attention. Previously BMT fellow @sloan_kettering, Hem/Onc fellow/chief @MayoClinic AZ. Views my own
451 Followers 316 FollowingAssistant Professor @StanfordBMT_CT focused on myeloma and cellular therapies | Alumna @fredhutch @UW @StanfordMedRes @dgsomucla @Stanford | Bay Area sports fan
292K Followers 2K FollowingNews and insights for physicians and clinical professionals from @ClevelandClinic | Research, case studies and the latest advances in patient care.
8K Followers 264 FollowingStem Cell Transplant physician and clinical researcher at MD Anderson Cancer Center; special interest in myeloma. Opinions expressed are my own
301 Followers 496 FollowingMedical director of Gastrointestinal cancers, FHCI, section chief at Fl Hosp, Past President of Moroccan American Chamberof commerce,ASCO member
10K Followers 739 FollowingProfessor, Dept of Leukemia, MD Anderson Cancer Center | Director, CAR-T Leukemia Program | #CLL #ALL #TcellRx | via @aiims_newdelhi | Tweets: my own opinions
21K Followers 3K FollowingProfessor, Leukemia; Executive Director-Cancer Medicine for MDACC Cancer Network | Director #BPDCN Program | Co-Section Head, MPN #MPNSM ;Tweets:my own opinions
7K Followers 2K FollowingPresident, Advocate Health Cancer National Service Line & Executive Director AH Wake Forest Baptist Comprehensive Cancer Center. #MPNs (Tweets-My Opinion)
1K Followers 1K FollowingPassionate about the diagnosis, management & care of patients with #multiplemyeloma #amyloidosis and #bloodcancer. And my family❤️. Tweets are my own.
1K Followers 631 FollowingClinical director of leukemia at MGH. MPN researcher. Associate Professor, Harvard Med School. Love teaching, mentoring, collaborating. Runner, mom, 🇲🇽
144 Followers 120 FollowingFocused on #SCLC | PI @drshieldsmd | #liquidbiopsy #methylation #subtypes #drugscreen | overcome #resistance | bench to bedside | IU Simon Comprehensive Cancer
4K Followers 2K FollowingDiMare Family Chair in Immunotherapy, Co-Leader GI Oncology Service Line/SDG, HPB surg oncologist @SylvesterCancer |Assoc Prof @UMiamiMedicine| husband & dad
11K Followers 2K FollowingA global education platform providing clinical updates on a range of lymphoma subtypes and CLL. Intended for HCPs. https://t.co/LDaomvPQF8 #lymsm
3K Followers 439 FollowingHosts @declangmurphy and @RenuEapen bring you the latest news from the world of urology, particularly GU Oncology. Subscribe wherever you get your podcasts